Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years
Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years
Enrolling by invitation · NCT07521371 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years | autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Enrolling by invitation | Not stated | 2026-04-09 | NCT07521371 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Healing Hope International | 6 |
| Kurve Technology Inc. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Healing Hope International | Spring | United States | 1 |